Hot Watch List: Kinross Gold Corporation (NYSE:KGC), Patterson-UTI Energy Inc. (NASDAQ:PTEN), NTELOS Holdings Corp. (NASDAQ:NTLS), Fresenius Medical Care (NYSE:FMS), Pfizer Inc. (NYSE:PFE)

It was reported on 30 July, that Kinross Gold Corp. (NYSE:KGC) is again considering cutting jobs at its Tasiast gold mine in Mauritania, Chief Executive Officer Paul Rollinson said on Wednesday, as the Canadian miner looks for ways to reduce costs at its higher-cost mines amid sliding metals prices. Kinross Gold Corporation (NYSE:KGC) belongs to Basic Materials sector. Its net profit margin is -40.60% and weekly performance is 5.81%. On last trading day company shares ended up $1.82. Kinross Gold Corporation (NYSE:KGC) distance from 50-day simple moving average (SMA50) is -15.05%.

Patterson-UTI Energy Inc. (NASDAQ:PTEN) today reported that for the month of July 2015, the Company had an average of 111 drilling rigs operating in the United States and four rigs in Canada. Patterson-UTI Energy Inc. (NASDAQ:PTEN) shares moved up 7.29% in last trading session and ended the day at $17.95. PTEN Gross Margin is 34.30% and its return on assets is 1.20%. Patterson-UTI Energy Inc. (NASDAQ:PTEN) quarterly performance is -14.96%.

NTELOS Holdings Corp. (NASDAQ:NTLS) announced on 28 July, operating and financial results for its second quarter ended June 30, 2015. In the fourth quarter of 2014, the Company announced a strategic refocus of its business operations in its western Virginia and West Virginia markets (“Western Markets” or “Markets”). The Company is currently in the process of winding down operations in its Eastern Markets, which it expects to complete by November 15, 2015. On 06 August, NTELOS Holdings Corp. (NASDAQ:NTLS) shares moved up 2.53% and was closed at $7.29. NTLS EPS growth in last 5 year was -26.10%. NTELOS Holdings Corp. (NASDAQ:NTLS) year to date (YTD) performance is 73.99%.

On 29 July, Rice Powell, chief executive officer of Fresenius Medical Care stated: “Our second quarter 2015 results showed a positive underlying performance. We are pleased with our revenue and earnings growth considering the negative currency impact on our International operations in the second quarter. We have made further progress with the integration of our Care Coordination operations. Our performance is in line with our full year guidance for 2015 and we are confident to achieve our long-term targets for 2020.” Fresenius Medical Care AG & Co. KGAA (NYSE:FMS) ended the last trading day at $41.85. Company weekly volatility is calculated as 1.00% and price to cash ratio as 41.66. Fresenius Medical Care AG & Co. KGAA (NYSE:FMS) showed a weekly performance of 1.97%.

U.K. competition authorities have accused Pfizer Inc. (NYSE:PFE) of inflating the price of an antiepileptic drug, leading to a 20-fold increase in the cost of the medicine to the country’s National Health Service. Pfizer Inc. (NYSE:PFE) shares decreased -1.81% in last trading session and ended the day at $35.17. PFE Gross Margin is 81.30% and its return on assets is 5.30%. Pfizer Inc. (NYSE:PFE) quarterly performance is 5.55%.

Leave a Reply

Your email address will not be published. Required fields are marked *